254 related articles for article (PubMed ID: 28339382)
1. Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2.
Deleruyelle LJ
Int J Pharm Compd; 2016; 20(6):447-454. PubMed ID: 28339382
[TBL] [Abstract][Full Text] [Related]
2. Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3.
Deleruyelle LJ
Int J Pharm Compd; 2017; 21(1):6-16. PubMed ID: 28346192
[TBL] [Abstract][Full Text] [Related]
3. Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1.
Deleruyelle LJ
Int J Pharm Compd; 2016; 20(5):359-364. PubMed ID: 28339370
[TBL] [Abstract][Full Text] [Related]
4. The effectiveness of sublingual and topical compounded bioidentical hormone replacement therapy in postmenopausal women: an observational cohort study.
Ruiz AD; Daniels KR
Int J Pharm Compd; 2014; 18(1):70-7. PubMed ID: 24881343
[TBL] [Abstract][Full Text] [Related]
5. Use of compounded bioidentical hormone therapy in menopausal women: an opinion statement of the Women's Health Practice and Research Network of the American College of Clinical Pharmacy.
McBane SE; Borgelt LM; Barnes KN; Westberg SM; Lodise NM; Stassinos M
Pharmacotherapy; 2014; 34(4):410-23. PubMed ID: 24390902
[TBL] [Abstract][Full Text] [Related]
6. Risks and effectiveness of compounded bioidentical hormone therapy: a case series.
Davis R; Batur P; Thacker HL
J Womens Health (Larchmt); 2014 Aug; 23(8):642-8. PubMed ID: 25111856
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of compounded bioidentical hormone replacement therapy.
Vigesaa KA; Downhour NP; Chui MA; Cappellini L; Musil JD; McCallian DJ
Int J Pharm Compd; 2004; 8(4):313-9. PubMed ID: 23924704
[TBL] [Abstract][Full Text] [Related]
8. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
Stephenson K; Neuenschwander PF; Kurdowska AK
Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
[TBL] [Abstract][Full Text] [Related]
9. Bioidentical menopausal hormone therapy: registered hormones (non-oral estradiol ± progesterone) are optimal.
L'Hermite M
Climacteric; 2017 Aug; 20(4):331-338. PubMed ID: 28301216
[TBL] [Abstract][Full Text] [Related]
10. ACOG Committee Opinion No. 420, November 2008: hormone therapy and heart disease.
American College of Obstetricians and Gynecologists Committee on Gynecologic Practice
Obstet Gynecol; 2008 Nov; 112(5):1189-92. PubMed ID: 18978127
[TBL] [Abstract][Full Text] [Related]
11. Bioidentical hormone replacement therapy. Customizing care for perimenopausal and menopausal women.
Romero M
Adv Nurse Pract; 2002 Nov; 10(11):47-8, 51-2. PubMed ID: 12478948
[No Abstract] [Full Text] [Related]
12. Conjugated equine estrogen and medroxyprogesterone acetate are associated with decreased risk of breast cancer relative to bioidentical hormone therapy and controls.
Zeng Z; Jiang X; Li X; Wells A; Luo Y; Neapolitan R
PLoS One; 2018; 13(5):e0197064. PubMed ID: 29768475
[TBL] [Abstract][Full Text] [Related]
13. Compounded Bioidentical Menopausal Hormone Therapy: ACOG Clinical Consensus No. 6.
Obstet Gynecol; 2023 Nov; 142(5):1266-1273. PubMed ID: 37856860
[TBL] [Abstract][Full Text] [Related]
14. Compounded bioidentical hormone therapy: identifying use trends and knowledge gaps among US women.
Pinkerton JV; Santoro N
Menopause; 2015 Sep; 22(9):926-36. PubMed ID: 25692877
[TBL] [Abstract][Full Text] [Related]
15. Bioidentical Estrogen for Menopausal Depressive Symptoms: A Systematic Review and Meta-Analysis.
Whedon JM; KizhakkeVeettil A; Rugo NA; Kieffer KA
J Womens Health (Larchmt); 2017 Jan; 26(1):18-28. PubMed ID: 27603786
[TBL] [Abstract][Full Text] [Related]
16. Compounded or confused? Bioidentical hormones and menopausal health.
Huntley AL
Menopause Int; 2011 Mar; 17(1):16-8. PubMed ID: 21427420
[TBL] [Abstract][Full Text] [Related]
17. The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
Parish SJ; Gillespie JA
Postgrad Med; 2017 Apr; 129(3):340-351. PubMed ID: 28132583
[TBL] [Abstract][Full Text] [Related]
18. Bioidentical hormone therapy in menopause: relevance in dermatology.
Borda LJ; Wong LL; Tosti A
Dermatol Online J; 2019 Jan; 25(1):. PubMed ID: 30710894
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of estrogen plus progestin on menopausal symptoms in women with systemic lupus erythematosus: a randomized, double-blind, controlled trial.
Cravioto MD; Durand-Carbajal M; Jiménez-Santana L; Lara-Reyes P; Seuc AH; Sánchez-Guerrero J
Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1654-63. PubMed ID: 22127965
[TBL] [Abstract][Full Text] [Related]
20. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
Rapp SR; Espeland MA; Shumaker SA; Henderson VW; Brunner RL; Manson JE; Gass ML; Stefanick ML; Lane DS; Hays J; Johnson KC; Coker LH; Dailey M; Bowen D;
JAMA; 2003 May; 289(20):2663-72. PubMed ID: 12771113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]